Trials / Sponsors / Kevin Flanigan
Kevin Flanigan
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subj Duchenne Muscular Dystrophy | Phase 2 | 2020-02-18 |
| Terminated | Spironolactone Versus Prednisolone in DMD Muscular Dystrophy, Duchenne | Phase 1 | 2018-12-05 |
| Completed | Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | 2017-11-06 |
| Withdrawn | Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | 2016-04-01 |